07/12/2004
Health research at forefront of Big Lottery Funding
Health and social inclusion are at the forefront of nine awards totalling over £2 million awarded by the Big Lottery Fund today.
Announcing today’s funding, Sir Clive Booth, Chair of the Big Lottery Fund, said research into debilitating diseases to help find better methods of treatment was crucial to supporting those who are most vulnerable.
One of the recipients of today's announcement is the Cystic Fibrosis Trust who has been awarded £509,759. People with Cystic Fibrosis who suffer from lung infections are subject to a draconian policy of segregation to prevent cross infections as lung damage is the cause of death in over 90% of people with the disease.
This medical project seeks to improve the quality of life of people with Cystic Fibrosis by helping develop faster and more accurate diagnosis of life-threatening lung infections, identify virulent strains of bacteria and develop more effective drugs to control infection.
Chief Executive of the Cystic Fibrosis Trust, Rosie Barnes said: "Transmission within the Cystic Fibrosis community of life-threatening lung infections can have a devastating effect on lives. This means that many individuals are often forced to live in isolation, unable to interact and share experiences with other Cystic Fibrosis sufferers.
"Thanks to the Big Lottery Fund award our ground-breaking research will investigate the spread of 'superbugs'. It will also improve speed and accuracy of diagnosis and treatment of respiratory infections. This will help those living with the UK's most common, life-threatening inherited disease have healthier and happier lives."
Other groups awarded funding include The Meningitis Trust; Age Concern, Surrey; Age Concern Scotland; Fathers Direct; and the Youth Action Network.
(MB)
Announcing today’s funding, Sir Clive Booth, Chair of the Big Lottery Fund, said research into debilitating diseases to help find better methods of treatment was crucial to supporting those who are most vulnerable.
One of the recipients of today's announcement is the Cystic Fibrosis Trust who has been awarded £509,759. People with Cystic Fibrosis who suffer from lung infections are subject to a draconian policy of segregation to prevent cross infections as lung damage is the cause of death in over 90% of people with the disease.
This medical project seeks to improve the quality of life of people with Cystic Fibrosis by helping develop faster and more accurate diagnosis of life-threatening lung infections, identify virulent strains of bacteria and develop more effective drugs to control infection.
Chief Executive of the Cystic Fibrosis Trust, Rosie Barnes said: "Transmission within the Cystic Fibrosis community of life-threatening lung infections can have a devastating effect on lives. This means that many individuals are often forced to live in isolation, unable to interact and share experiences with other Cystic Fibrosis sufferers.
"Thanks to the Big Lottery Fund award our ground-breaking research will investigate the spread of 'superbugs'. It will also improve speed and accuracy of diagnosis and treatment of respiratory infections. This will help those living with the UK's most common, life-threatening inherited disease have healthier and happier lives."
Other groups awarded funding include The Meningitis Trust; Age Concern, Surrey; Age Concern Scotland; Fathers Direct; and the Youth Action Network.
(MB)
Related UK National News Stories
Click here for the latest headlines.
10 April 2006
Teenager in court over schoolboy murder
A teenager has appeared in court charged with the murder of 11-year-old schoolboy Joe Geeling. The case of the 14-year-old, who cannot be named for legal reasons, has been sent to the crown court.
Teenager in court over schoolboy murder
A teenager has appeared in court charged with the murder of 11-year-old schoolboy Joe Geeling. The case of the 14-year-old, who cannot be named for legal reasons, has been sent to the crown court.
04 January 2005
£2.5m to support cystic fibrosis gene therapy research
Health Minister, Lord Warner, has announced the winning bids for £2.5 million to support further research into gene therapy for cystic fibrosis (CF).
£2.5m to support cystic fibrosis gene therapy research
Health Minister, Lord Warner, has announced the winning bids for £2.5 million to support further research into gene therapy for cystic fibrosis (CF).
27 August 2013
MS And Parkinson's Sufferers Told They Are Fit To Work
Almost half of people with some progressive conditions, including Parkinson's, who put in a claim for the sickness benefit Employment and Support Allowance (ESA), are being told they will recover enough to look for work in the future.
MS And Parkinson's Sufferers Told They Are Fit To Work
Almost half of people with some progressive conditions, including Parkinson's, who put in a claim for the sickness benefit Employment and Support Allowance (ESA), are being told they will recover enough to look for work in the future.
09 January 2009
First Breast Cancer Gene-Free Baby Born
The first British baby genetically-selected to be free of the breast cancer gene, has been born. Doctors at University College London said the girl and her mother were doing "very well". The baby grew from an embryo screened to ensure it did not contain the faulty BRCA 1 gene, which passes cancer down generations.
First Breast Cancer Gene-Free Baby Born
The first British baby genetically-selected to be free of the breast cancer gene, has been born. Doctors at University College London said the girl and her mother were doing "very well". The baby grew from an embryo screened to ensure it did not contain the faulty BRCA 1 gene, which passes cancer down generations.
07 May 2008
Warning To Hospitals Over 'New' Superbug
Hospitals across the UK could be facing another so-called 'superbug', scientists have warned. The study by the Wellcome Trust Sanger and the University of Bristol said Stenotrophomonas maltophilia has a "remarkable capacity" for drug resistance.
Warning To Hospitals Over 'New' Superbug
Hospitals across the UK could be facing another so-called 'superbug', scientists have warned. The study by the Wellcome Trust Sanger and the University of Bristol said Stenotrophomonas maltophilia has a "remarkable capacity" for drug resistance.